Publications

1. Allen O 4th, Coombes BJ, Pazdernik V, Gisabella B, Hartley J, Biernacka JM, Frye MA, Markota M, Pantazopoulos H. Differential serum levels of CACNA1C, circadian rhythm and stress response molecules in subjects with bipolar disorder: Associations with genetic and clinical factors. J Affect Disord. 2024 Dec 15; 367:148-156 Epub 2024 Sept 02
   View PubMed
2. Markota M, Morgan RJ 3rd, Leung JG. Updated rationale for the initial antipsychotic selection for patients with schizophrenia. Schizophrenia (Heidelb). 2024 Sep 2; 10 (1):74 Epub 2024 Sept 02
   View PubMed
3. Leung JG, Bye KN, Leloux MR, Markota M, Allen ND. Making Clozapine Therapeutic Drug Monitoring Essential for Optimal Patient Care: Letter to the Editor. Ther Drug Monit. 2024 Jun 06. [Epub ahead of print]
   View PubMed
4. Leung JG, Allen ND, Markota M. A case series of clozapine titrations affected by inflammatory processes. Schizophr Res 2024 Jun; 268:94-97 Epub 2023 Aug 24
   View PubMed
5. Elmaghraby R, Pines A, Geske JR, Coombes BJ, Leung JG, Croarkin PE, Markota M, Bobo WV. Risk of Newly Diagnosed Psychotic Symptoms in Youth Receiving Medications for Attention-Deficit/Hyperactivity Disorder. JAACAP Open. 2024 Jun; 2 (2):135-144 Epub 2024 Feb 05
   View PubMed
6. Leung JG, Zhang L, Markota M, Ellingrod VL, Gerberi DJ, Bishop JR. A systematic review of clozapine-associated inflammation and related monitoring. Pharmacotherapy. 2023 Dec; 43 (12):1364-1396 Epub 2023 Oct 31
   View PubMed
7. Gardea-Resendez M, Taylor-Desir MJ, Romo-Nava F, Bond D, Vallender EJ, Cuellar-Barboza AB, Prieto ML, Nunez N, Veldic M, Ozerdem A, Singh B, Markota M, Colby CL, Coombes BJ, Biernacka JM, McElroy SL, Frye MA. Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder. J Clin Psychopharmacol. 2022 Feb 25 [Epub ahead of print]
   View PubMed
8. Markota M, Croarkin PE, Bobo WV. Positive Urine Drug Screens and External Mortality in Teenagers Who Present for Medical Care. J Clin Psychiatry. 2022 Jan 11; 83 (1)
   View PubMed
9. Leung JG, Narayanan PP, Markota M, Miller NE, Philbrick KL, Burton MC, Kirchoff RW. Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey. Front Psychiatry. 2022; 13:856938 Epub 2022 May 10
   View PubMed
10. Keser Z, Buchl SC, Seven NA, Markota M, Clark HM, Jones DT, Lanzino G, Brown RD Jr, Worrell GA, Lundstrom BN. Electroencephalogram (EEG) With or Without Transcranial Magnetic Stimulation (TMS) as Biomarkers for Post-stroke Recovery: A Narrative Review. Front Neurol. 2022; 13:827866 Epub 2022 Feb 22
    View PubMed
11. Markota M, Coombes BJ, Bieber ED, Kirchoff RW, Bobo WV, Croarkin PE. Relative Age Effect on Problematic Alcohol Use in Adolescents. J Child Adolesc Psychopharmacol. 2021 Dec; 31 (10):692-696 Epub 2021 July 27
    View PubMed
12. Kirchoff RW, Mohammed NM, McHugh J, Markota M, Kingsley T, Leung J, Burton MC, Chaudhary R. Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5 (2):495-501 Epub 2021 Apr 08
    View PubMed
13. Coombes BJ, Markota M, Mann JJ, Colby C, Stahl E, Talati A, Pathak J, Weissman MM, McElroy SL, Frye MA, Biernacka JM. Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores. Transl Psychiatry. 2020 Sep 18; 10 (1):314 Epub 2020 Sept 18
    View PubMed
14. Ho AM, Cabello-Arreola A, Markota M, Heppelmann CJ, Charlesworth MC, Ozerdem A, Mahajan G, Rajkowska G, Stockmeier CA, Frye MA, Choi DS, Veldic M. Label-free proteomics differences in the dorsolateral prefrontal cortex between bipolar disorder patients with and without psychosis. J Affect Disord. 2020 Jun 1; 270:165-173 Epub 2020 Apr 08
    View PubMed
15. Markota M, McKean AJ, Romanowicz M, Schak KM, Croarkin PE, Vande Voort JL. Rehospitalization to a child and adolescent psychiatry unit: Role of trauma and bullying. Gen Hosp Psychiatry. 2018 Nov - Dec; 55:10-14 Epub 2018 Aug 30
    View PubMed
16. Markota M, Coombes BJ, Larrabee BR, McElroy SL, Bond DJ, Veldic M, Colby CL, Chauhan M, Cuellar-Barboza AB, Fuentes M, Kung S, Prieto ML, Rummans TA, Bobo WV, Frye MA, Biernacka JM. Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder. Transl Psychiatry. 2018 Sep 10; 8 (1):188 Epub 2018 Sept 10
    View PubMed
17. Pantazopoulos H, Wiseman JT, Markota M, Ehrenfeld L, Berretta S. Decreased Numbers of Somatostatin-Expressing Neurons in the Amygdala of Subjects With Bipolar Disorder or Schizophrenia: Relationship to Circadian Rhythms. Biol Psychiatry. 2017 Mar 15; 81 (6):536-547 Epub 2016 Apr 16
    View PubMed
18. Markota M, Morgan RJ. Treatment of Generalized Anxiety Disorder with Gabapentin. Case Rep Psychiatry. 2017; 2017:6045017 Epub 2017 Dec 14
    View PubMed
19. Markota M, Rummans TA, Bostwick JM, Lapid MI. Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies. Mayo Clin Proc. 2016 Nov; 91 (11):1632-1639
    View PubMed
20. Berretta S, Pantazopoulos H, Markota M, Brown C, Batzianouli ET. Losing the Sugar Coating: Potential Impact of Perineuronal Net Abnormalities on Interneurons in Schizophrenia Schizophr Res.. 2015 Sep; 167(1-3):18-27.
    
21. Pantazopoulos H, Markota M, Jaquet F, Ghosh D, Wallin A, Santos A, Caterson B, Berretta S. Aggrecan and Chondroitin-6-sulfate Abnormalities in Schizophrenia and Bipolar Disorder: a Postmortem Study on the Amygdala Transl Psychiatry. 2015 Jan 20; 5:e496.
    
22. Markota M, Mehta U, Solis M. Highlights from the Biennial International Congress on Schizophrenia Research (ICOSR), March 28-April 1, 2015. Clinical Schizophrenia and Related Psychoses. 2015; 9(2):60-4.
    View PubMed
23. Markota M, Sin J, Pantazopoulos H, Jonilionis R, Berretta S. Reduced Dopamine Transporter Expression in the Amygdala of Subjects Diagnosed with Schizophrenia Schizophr Bull.. 2014; 40:984-91.
    
24. Markota M, Vranic A, Bresjanac M. Contemporary psychosurgery: Deep brain stimulation for the treatment of refractory depression Zdravstveni Vestnik. 2010; 79:433-441.